Navigation Links
China-Biotics, Inc. Reports Record Quarterly Net Sales for the Third quarter of Fiscal Year 2011
Date:2/9/2011

SHANGHAI, Feb. 9, 2011 /PRNewswire-Asia-FirstCall/ -- China-Biotics, Inc. (Nasdaq: CHBT) ("China-Biotics" or "the Company"), a leading developer, manufacturer and distributor of probiotics products in China, today reported its unaudited financial results for the third quarter and nine months of its 2011 fiscal year ended December 31, 2010.

Third Quarter FY2011 Highlights

  • Net sales increased 39.0% y-o-y to $32.4 million;
  • Bulk products sales increased 142% y-o-y to $14.3 million;  
  • GAAP net income was $13.3 million, or $0.59 per diluted share;
  • Excluding the non-cash changes in the fair value of convertible notes, non-GAAP net income was $10.4 million, or non-GAAP diluted EPS of $0.47;
  • Cash and cash equivalents were $132.3 million.

  • Mr. Jinan Song, China-Biotics' Chairman and CEO commented, "We are pleased to report a solid third quarter as our successful strategic shift from retail to bulk products continues to show positive results. As dairy producers introduce greater quantities and varieties of value-added products to the market, our core probiotic cultures are gaining greater acceptance due to reliable product safety, good technical service, and competitive pricing. Furthermore, additive probiotics for the animal feed market are also expanding due to tighter government regulations on the overuse of antibiotics."

    "We are also seeing more yogurt producers embracing functional probiotic additives in their products as dairy consumers in major cities are looking for better nutritional benefits. Chinese consumers are increasingly using probiotics due to their rising health consciousness."

    "Our successful transition from business-to-consumer model to business-to-business model enables us to increase operating leverage and low
    '/>"/>

    SOURCE China-Biotics, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11

    Related medicine technology :

    1. China-Biotics, Inc. Prices $69 Million Public Offering of Common Stock
    2. China-Biotics, Inc. Begins Trial Production at New Facility, Affirms 2010 Revenue Guidance
    3. China-Biotics, Inc. to Hold 2009 Annual Meeting of Stockholders on March 5, 2010
    4. China-Biotics, Inc. Announces US$20 million Share Buyback Program
    5. China-Biotics, Inc. Comments on Market Rumors
    6. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
    7. Spherix Reports Second Quarter Earnings
    8. Tapestry Reports Second Quarter 2007 Results
    9. Callisto Reports on Second-Quarter 2007 Milestones
    10. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
    11. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:10/1/2014)... 2014  Varian Medical Systems (NYSE: VAR ... the fourth quarter of fiscal year 2014 following the ... The news release will be followed by a teleconference ... The news release and a link to the conference ... at: www.varian.com/investor .  To access the teleconference call ...
    (Date:10/1/2014)... 2014 Quantum Materials Corp (OTCQB:QTMM) today ... photoactive quantum dots for use in next-generation ... advantages for solar power generation, the high cost ... dots with which to develop thin film solar ... utilization and acceptance. The company is also seeking ...
    (Date:10/1/2014)... , Oct. 1, 2014 ... a clinical-stage biopharmaceutical company focused on cardio-renal, ... results from its 371 patient Phase 2b ... constipation-predominant irritable bowel syndrome (IBS-C).  Results from ... meaningful improvement in IBS-C symptoms for tenapanor-treated ...
    Breaking Medicine Technology:Varian Medical Systems Schedules Fourth Quarter FY2014 News Release and Conference Call 2Quantum Materials Scaling Up Photoactive Quantum Dot Production for Solar Power Generation 2Quantum Materials Scaling Up Photoactive Quantum Dot Production for Solar Power Generation 3Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients 2Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients 3Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients 4Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients 5Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients 6
    ... EAST RUTHERFORD, N.J., Oct. 20 Cambrex Corporation (NYSE: ... Silver Innovation Award at the 2009 CPhI Event for ... award was accepted by Dr. Jayne E. Muir (Market ... technology to a panel of judges at this important ...
    ... 20 Abaxis, Inc. (Nasdaq: ABAX ), a medical ... conference call to discuss its financial results for the second ... call will be at 4:15 p.m. ET on Tuesday, October ... 858-4600 to access the conference call, or can listen via ...
    Cached Medicine Technology:Cambrex Continuous-Flow Microwave-Assisted Organic Synthesis Technology Wins 2009 Silver Innovation Award 2Abaxis to Report Second Quarter Fiscal 2010 Financial Results Tuesday, October 27, 2009 2
    (Date:10/1/2014)... (October 1, 2014) Despite a policy focus ... developmental disabilities, this vulnerable population continues to have ... The Journal of the American Dental Association ... and Tufts University School of Dental Medicine report ... influencing at-home oral care provided by caregivers to ...
    (Date:10/1/2014)... Insuranceragents.info has released a new blog post ... for vulnerable family members. , Life insurance plans provide ... the family should always carry a life insurance policy ... rest of the family. , Clients can choose ... from temporary coverage or from a permanent policy. No ...
    (Date:10/1/2014)... October 01, 2014 Phoseon Technology, the ... continues to expand the business worldwide. This rapid growth ... additional capacity for manufacturing efforts. The company has experienced ... five years and expects this growth to continue in ... technology gains worldwide adoption. , “We are very ...
    (Date:10/1/2014)... DURHAM, N.C. A new genetic finding from Duke ... hostility, anxiety and depression might also be hard-wired to ... diabetes and heart disease. , An estimated 13 percent ... the genetic susceptibility, and knowing this could help them ... healthy diet, exercise and stress management. , "Genetic susceptibility, ...
    (Date:10/1/2014)... NJ (PRWEB) October 01, 2014 Diet Doc ... their intentions to lose weight and their dieting attempts could ... fatty foods. Including hormone diet treatments into their ... allows patients to see fast and effective weight loss results, ... begin forming healthy habits to maintain their weight for the ...
    Breaking Medicine News(10 mins):Health News:To improve oral health of adults with developmental disabilities, support caregivers 2Health News:To improve oral health of adults with developmental disabilities, support caregivers 3Health News:Life Insurance for Families - Clients Can Compare Affordable Rates Online! 2Health News:Phoseon Technology Continues to Drive Growth Worldwide 2Health News:Gene interacts with stress and leads to heart disease in some people 2Health News:Diet Doc Announces Their New Version of the Hormone Diet Plan to Target, Attack and Burn Fat Without Dangerous Side Effects 2Health News:Diet Doc Announces Their New Version of the Hormone Diet Plan to Target, Attack and Burn Fat Without Dangerous Side Effects 3Health News:Diet Doc Announces Their New Version of the Hormone Diet Plan to Target, Attack and Burn Fat Without Dangerous Side Effects 4
    ... , TUESDAY, Nov. 22 (HealthDay News) -- ,Taking ... by the brand name Tylenol) over time can lead to ... to a new study. These "staggered overdoses" can occur ... more acetaminophen than they should, explained Dr. Kenneth Simpson, author ...
    ... HealthDay Reporter , TUESDAY, Nov. 22 (HealthDay News) -- As ... related health problems, a new study finds. In 2009, ... reactions to beverages such as Monster and Rockstar than they ... released Tuesday. More than 13,000 ER visits related to ...
    ... -- Elderly black patients who require surgery for an intestinal ... the hospital than white patients, a new study has found. ... black patients had the same health insurance as white patients, ... pouches in the lining of the intestine become infected or ...
    ... Langone Medical Center researchers have discovered the novel protective ... study, published in the November issue of journal ... against acute pancreatitis, a sudden dangerous swelling and inflammation ... demonstrate that an abundance of dendritic cells are needed ...
    ... Nov. 22 (HealthDay News) --,College students tend to smoke when ... study. "Students are using social events and work as ... author, Nikole Cronk, an assistant professor of family and community ... a news release. "This research is important for those working ...
    ... News) -- A weakened immune system and unhealthy lifestyle habits ... cancer, according to a new study. The researchers also ... HIV infection might reduce cancer risk. The primary goal ... risk of cancer in HIV-infected patients, was to determine how ...
    Cached Medicine News:Health News:Too Much Acetaminophen Over Time May Damage Liver 2Health News:ER Visits for Energy-Drink Ills Soar in U.S. 2Health News:ER Visits for Energy-Drink Ills Soar in U.S. 3Health News:More Blacks Die in Hospital After Diverticulitis Surgery 2Health News:Dendritic cells protect against acute pancreatitis 2Health News:Dendritic cells protect against acute pancreatitis 3Health News:College Students Smoke When They Party, Drink and Work 2Health News:HIV Patients at Heightened Risk for Certain Cancers 2
    ... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
    ... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
    ... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
    ... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
    Medicine Products: